Searched for
ANTIBIOTICS RESEARCH
Scanning cancer, up close & personal: A revolution is underway in cancer diagnosisA gene-based test called next-generation sequencing can identify precise mutations, which can then be treated with targeted therapies. Sinc...- A new nanotech breakthrough could help heal dangerous wounds antibiotics can’t treatScientists are using nanomaterials to heal stubborn wounds that resist antibiotic treatment through a new era of smart wound care. These li...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 26%Just look at developments in the past 48 hours. The war between Iran and Israel resumed, but within hours Tehran said it had halted all off...
- How an Australian connection helped Shaily Mehrotra build a Rs 1,500-crore Indian skincare brandA gap in science-backed skincare products in the Indian market prompted Shaily Mehrotra to start Fixderma, with an aim to solve common skin...
- The gut-brain bombshell: How bacteria in babies may hold the key to preventing Autism, ADHDNew research reveals a significant link between a baby's early gut bacteria and future brain health, potentially influencing the risk of co...
- If you have the patience, you can achieve innovation milestones, says Wockhardt chairman Habil KhorakiwalaWockhardt Hospitals is set to launch its antibiotic Zaynich in the US. Zahabiya Khorakiwala will lead US operations. The drug is expected t...
- Infosys, Tech Mahindra, TCS and other IT stocks jump up to 5%. What’s driving the rally?Indian IT stocks rose sharply on Monday, lifting the Nifty IT index nearly 3%, as investors reassessed AI-related fears, attracted by attra...
- FDA approval puts Wockhardt’s Zaynich in $9 billion antibiotics marketWockhardt's new antibiotic, Zaynich, has received US FDA approval. This drug uses a novel mechanism to fight drug-resistant bacteria. It ta...
- More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 22%As the market grappled with confusion over the Strait of Hormuz, there was more trouble for the bulls. After a few days of respite, another...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- HAB Pharma merges Signature Phytochemicals, eyes Rs3,000 crore revenue by 2030HAB Pharma and Signature Phytochemicals have merged, creating a consolidated entity with a turnover of Rs600 crore. This strategic move aim...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%Here’s a thing investors in equity need to keep in mind. A large part of the upmove one might see in the next one or two trading sessions w...
- Trump-Xi meeting crucial for global economic stability: Shaun ReinA high-stakes meeting between US President Trump and Chinese President Xi Jinping is closely watched for signs of stability amid escalating...
- Venus Remedies expands Latin America presence with Argentina nod for antibioticVenus Remedies has received approval in Argentina for its antibiotic Ceftriaxone. This marks a significant step in the company's Latin Amer...
- In 1928, Alexander Fleming Returned From Vacation: Found Mold in a Petri Dish and Discovered Penicillin, Changing Medicine ForeverA forgotten petri dish led to a groundbreaking discovery. Alexander Fleming observed mold inhibiting bacteria, a finding later developed in...
- Common weedkiller in Australian homes linked to ‘superbug’ threat, study warns of rising antimicrobial resistance beyond antibiotic misuseA common weedkiller used widely in Australia may be contributing to the rise of superbugs. New research suggests this chemical can drive ba...
- Urgent need to develop antibiotics for newborns, say global expertsOver the last decade, AMR has worsened to the point where around 50-70 per cent of common pathogens show a high degree of resistance to ava...
- Bugworks Research set for pre-clinical drug trialsCARB-X was formed two years ago as a public-private partnership to tackle the rising menace of antibiotic resistance.
- World running out of antibiotics: WHOPharmaceutical companies and researchers must urgently focus on new antibiotics against certain types of extremely serious infections, said...
Load More
